COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events
The COCOON trial compared SOC with prophylactic management for treatment-related dermatologic events with amivantamab plus lazertinib. In this Q&A, Dr. Martin F. Dietrich explains the prophylactic regimen’s impact on effects of the skin, scalp, and nails. APP Alyson Singer offers best practices for patient education. Read more
Determining the Most Effective Chemotherapy Regimen in Patients With Advanced KRAS-Mutated NSCLC: the NVALT22 study
Sophie M. Ernst, MD+more
Study tests combination of taxanes with an angiogenesis inhibitor in search for better outcomes for patients with advanced KRAS-mutated NSCLC. Read more
Novel Targets and Therapies: KEAP1- and NFE2L2-Mutant Squamous Cell Lung Cancer
Paul Paik, MD+more
During an interview with ILCN, Drs. Paul Paik and Jonathan Reiss discuss the implications of KEAP1 and NFE2L2 mutations in NSCLC. Read more
Role of Liquid Biopsy in the Clinic Growing
Leah LawrenceLung cancer specialists are slowly being faced with the challenge of how to balance the benefits of next-generation tumor tissue testing against those of liquid biopsy in the clinic. During […] Read more
Multidisciplinary Tumor Boards: Six Eyes See More than Two
Mihaela Aldea, MD, PhD+more
See how specialists in France use MTBs to develop the most beneficial treatment strategies for patients and to decrease inequity in cancer care. Read more
Unplanned Hospital Care in Patients With NSCLC
Manan P. Shah, MD+more
Study findings suggest that a significant number of unplanned hospital visits for patients with lung cancer might be avoidable. Read more
Predicting Early Weight Loss in Radiotherapy
Dirk De Ruysscher, MD, PhDStudy shows emerging techniques may improve prognostic and predictive models in identifying patients at risk for early weight loss. Read more
In Brief for February 9, 2022
John AustinTTLC goes virtual. Positive results reported for pembrolizumab. GO2 Foundation names Chief of Healthcare Delivery. Read more
When facing a grave illness, especially for the first time, many people are worried, frightened, and overwhelmed. They may have difficulty focusing their attention on daily tasks and experience skewed […] Read more
Multifaceted Initiative Launches Aimed at Reducing Lung Cancer Deaths 25% by 2030
Raymond U. Osarogiagbon, MBBS, FACPThe Baptist Cancer Center in Memphis, Tennessee, has launched a new initiative that comprises seven components that will address prevention, diagnosis, and treatment of lung cancer through smoking cessation, low-dose […] Read more
Data from multiple groups1,2 have shown the significant impact of COVID-19 infection among patients with malignancies, leading to high overall morbidity and mortality; this includes our own institution,3 which saw […] Read more